Resmed Inc. buy Morgan Stanley
Start price
21.10.25
/
50%
€230.40
Target price
21.10.26
€261.08
Performance (%)
-6.47%
Price
03.12.25
€215.50
Summary
This prediction is currently active. With a performance of -6.47%, the BUY prediction for Resmed Inc. by Morgan_Stanley is down slightly. This prediction currently runs until 21.10.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -2.045% | -2.045% |
| iShares Core DAX® | 0.142% | -1.511% |
| iShares Nasdaq 100 | 0.833% | -2.600% |
| iShares Nikkei 225® | -0.829% | -7.040% |
| iShares S&P 500 | 0.008% | -1.196% |
Comments by Morgan_Stanley for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its price target raised by analysts at Morgan Stanley from $298.00 to $304.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat